Abstract: The present invention relates to a method for producing randomly mutated nucleic acid sequences and corresponding proteins or polypeptides. More particularly, the mutated nucleic acid sequences are generated by submitting a DNA template to polymerase chain reaction in a reaction buffer comprising an alcohol.
Abstract: The present invention relates to protein engineering for production of analogs of MB-1. MB-1 analogs are more stable to different biochemical conditions than the native protein, and allow for improving the supplying of essential amino acids to human and animals. De novo synthesis of MB-1 analogs is principally targeted to enhance availability of essential amino acids required for farm animal production or human health.
Type:
Application
Filed:
July 24, 2003
Publication date:
October 7, 2004
Applicant:
AGROTERRA BIOTECH INC.
Inventors:
Marc Beauregard, Mylene-Claude Gagnon, Alain Doucet, Martin Williams
Abstract: The present invention relates to protein engineering for production of analogs of MB-1. MB-1 analogs are more stable to different biochemical conditions than the native protein, and allow for improving the supplying of essential amino acids to human and animals. De novo synthesis of MB-1 analogs is principally targeted to enhance availability of essential amino acids required for farm animal production or human health.
Type:
Application
Filed:
October 18, 2002
Publication date:
June 26, 2003
Applicant:
AGROTERRA BIOTECH INC.
Inventors:
Marc Beauregard, Mylene-Claude Gagnon, Alain Doucet, Martin Williams